Eurobio Scientific S.A.
ALERS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 18.6% | -14.4% | -17.4% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 46.4% | 44% | 42.6% | 52.8% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€0 | €0 | -€0 | -€0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | €0 | €0 | €0 | €0 |
| % Margin | 8.6% | 7.8% | 20.2% | 39% |
| Other Income/Exp. Net | €0 | -€0 | -€0 | €0 |
| Pre-Tax Income | €0 | €0 | €0 | €0 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | €0 | €0 | €0 | €0 |
| % Margin | 2.6% | 3.7% | 16.3% | 32.8% |
| EPS | 0.39 | 0.43 | 2.2 | 5.58 |
| % Growth | -9.3% | -80.5% | -60.6% | – |
| EPS Diluted | 0.39 | 0.43 | 2.2 | 5.57 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | €0 | €0 | €0 | €0 |
| % Margin | 13.2% | 18.8% | 26.5% | 43.1% |